IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women

byQueen Mary, University of LondonCredit: CC0 Public DomainThe Queen Mary University of London professor leading an international breast cancer study says anastrozole—rather than tamoxifen—shoul

Oncology December 22,2023

IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women

byQueen Mary, University of LondonCredit: CC0 Public DomainThe Queen Mary University of London professor leading an international breast cancer study says anastrozole—rather than tamoxifen—shoul

Oncology December 22,2023

Pregnancy-related heart failure tied to higher cancer risk

(HealthDay)—Patients with peripartum cardiomyopathy (PPCM) are more likely to have cancer before PPCM diagnosis and more likely to develop cancer after PPCM, according to a study published in the Dece

OB & GYN December 22,2023

Pregnancy-related heart failure tied to higher cancer risk

(HealthDay)—Patients with peripartum cardiomyopathy (PPCM) are more likely to have cancer before PPCM diagnosis and more likely to develop cancer after PPCM, according to a study published in the Dece

OB & GYN December 22,2023

Shutting down backup genes leads to cancer remission in mice

by Jim Lynch,University of MichiganAbhinav Achreja, PhD, Research Fellow at the University of Michigan Biomedical Engineering and Deepak Nagrath, Ph.D. Associate Professor of Biomedical Engineer

Oncology December 22,2023

Shutting down backup genes leads to cancer remission in mice

by Jim Lynch,University of MichiganAbhinav Achreja, PhD, Research Fellow at the University of Michigan Biomedical Engineering and Deepak Nagrath, Ph.D. Associate Professor of Biomedical Engineer

Oncology December 22,2023

First-in-human trial for new lung cancer immunotherapy

byCancer Research UKCancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lu

Oncology December 22,2023

First-in-human trial for new lung cancer immunotherapy

byCancer Research UKCancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lu

Oncology December 22,2023

Dissemination of bone metastasis linked with bone remodeling

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainYears to decades after breast tumors have been removed, cancer may return or metastasize in other organs. Bone is frequently affected

Orthopedics & Sports medicine December 22,2023

Dissemination of bone metastasis linked with bone remodeling

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainYears to decades after breast tumors have been removed, cancer may return or metastasize in other organs. Bone is frequently affected

Orthopedics & Sports medicine December 22,2023

Many lung cancer patients receive meds that prolong QTc interval

(HealthDay)—A considerable proportion of patients with lung cancer are prescribed medications that prolong the corrected QT (QTc) interval, limiting their eligibility for clinical trials, according to

Oncology December 22,2023

Many lung cancer patients receive meds that prolong QTc interval

(HealthDay)—A considerable proportion of patients with lung cancer are prescribed medications that prolong the corrected QT (QTc) interval, limiting their eligibility for clinical trials, according to

Oncology December 22,2023

A new role for a triple-negative breast cancer target

by Katherine Unger Baillie,University of PennsylvaniaLed by Penn Vet scientists, a new study reveals that the protein deltaNp63, whichfosters the initiation and progression of triple-negat

Oncology December 22,2023

A new role for a triple-negative breast cancer target

by Katherine Unger Baillie,University of PennsylvaniaLed by Penn Vet scientists, a new study reveals that the protein deltaNp63, whichfosters the initiation and progression of triple-negat

Oncology December 22,2023

New optimism on myelodysplastic syndromes

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainPhysician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have publish

Oncology December 22,2023

New optimism on myelodysplastic syndromes

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainPhysician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have publish

Oncology December 22,2023

Ultrasound blasts potent glioblastoma drug into brain tumor

byNorthwestern UniversityCredit: CC0 Public DomainOne of most potent drugs for treatment of glioblastoma, the most deadly type of brain tumor, can't be used in patients because of two proble

Oncology December 22,2023

Ultrasound blasts potent glioblastoma drug into brain tumor

byNorthwestern UniversityCredit: CC0 Public DomainOne of most potent drugs for treatment of glioblastoma, the most deadly type of brain tumor, can't be used in patients because of two proble

Oncology December 22,2023

Leukemia vulnerability discovered causing drug sensitivity

byJosep Carreras Leukaemia Research InstituteCells from acute lymphoblastic leukemia, a disease against which treatment with glutathione inhibitors has demonstrated preclinical efficacy, dying b

Oncology December 22,2023

Leukemia vulnerability discovered causing drug sensitivity

byJosep Carreras Leukaemia Research InstituteCells from acute lymphoblastic leukemia, a disease against which treatment with glutathione inhibitors has demonstrated preclinical efficacy, dying b

Oncology December 22,2023